EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer

Yina T Zambrano-O, Alejandro Mejía-Garcia, P Daniela Morales, Hsuan Megan Tsao, Laura Rey-Vargas, Wendy Montero-Ovalle, Carlos A Huertas-Caro, M C Sanabria-Salas, Julián Riaño-Moreno, Juliana L Rodriguez, Carlos A Orozco, Liliana Lopez-Kleine und 2 weitere

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07557-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Yina T Zambrano-O und 13 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Cl. 1 #9-85, Bogotá, Colombia. ytzambrano@cancer.edu.co. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cancerología, National Institute of Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer health disparities among racial and ethnic populations significantly burden health systems due to unequal access to early detection, treatment, and healthcare resources. These disparities lead to worse outcomes and increased costs from delayed diagnoses, advanced treatments, and prolonged care. Genetic differences can also influence cancer susceptibility and treatment response, thus analyzing genetic ancestry is essential for uncovering genetic factors that may contribute to these disparities. Utilizing data from clinical multigene cancer panels to infer genetic ancestry offers a valuable approach to understand population structure and the impact of individual ancestries in development of complex diseases.

Aim

To evaluate the accuracy of global ancestry inference using genetic markers from the TruSight™ Hereditary Cancer Panel, which was used to investigate hereditary cancer syndromes in a cohort of 116 female cancer patients at the Colombian National Cancer Institute. Additionally, to compare these results with genetic ancestry estimations from traditional genome-wide markers.

Results

Our results demonstrate a strong correlation between global genetic ancestry inferred with markers captured from TruSight TM panel (4785 markers) and Whole Genome Sequencing (WGS, 8 million markers in admixed populations. The correlation values were 0.96 ( p < 0.0001) for the Native American and European ancestry components, and 0.99 ( p < 0.0001) for the African ancestry fraction. Genetic ancestry mean proportions in the Colombian cohort were 45.7%, 46.2%, and 8.11% for the European, the Native American, and the African components, respectively.

Conclusion

This study demonstrates the accuracy of ancestry inference from clinical panel data offering a promising approach for understanding cancer health disparities in admixed populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkers, TumorBreast NeoplasmsHumansFemaleColombiaGenetic Predisposition to DiseaseMiddle AgedAdultGenetic MarkersAgedWhole Genome Sequencing

Stichwörter der Autor:innen

Admixed populationsClinical panelsDiversityGenetic ancestry

Substanzen

Biomarkers, TumorGenetic Markers

Autor:innen und Institutionen

  • Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Cl. 1 #9-85, Bogotá, Colombia. ytzambrano@cancer.edu.co.
  • Universidad Nacional de Colombia - sede Bogotá, Bogotá, Colombia. ytzambrano@cancer.edu.co.
  • Department of Human Genetics, McGill University, Montreal, Canada.
  • Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Cl. 1 #9-85, Bogotá, Colombia.
  • Universidad Nacional de Colombia - sede Bogotá, Bogotá, Colombia.
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, M5G 2C1, Canada.

Förderung

  • Instituto Nacional de Cancerología
  • National Institute of Cancer

Zitieren

APA

Zambrano-O, Y. T., Mejía-Garcia, A., Morales, P. D., Tsao, H. M., Rey-Vargas, L., Montero-Ovalle, W., Huertas-Caro, C. A., Sanabria-Salas, M. C., Riaño-Moreno, J., Rodriguez, J. L., Orozco, C. A., Lopez-Kleine, L., Jordan, I. K., & Serrano-G, S. J. (2025). Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07557-7

Vancouver

Zambrano-O YT, Mejía-Garcia A, Morales PD, Tsao HM, Rey-Vargas L, Montero-Ovalle W, et al. Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07557-7

BibTeX
@article{ZambranoO2025,
  author = {Zambrano-O, Yina T and Mejía-Garcia, Alejandro and Morales, P Daniela and Tsao, Hsuan Megan and Rey-Vargas, Laura and Montero-Ovalle, Wendy and Huertas-Caro, Carlos A and Sanabria-Salas, M C and Riaño-Moreno, Julián and Rodriguez, Juliana L and Orozco, Carlos A and Lopez-Kleine, Liliana and Jordan, I King and Serrano-G, Silvia J},
  title = {Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07557-7}
}
Kostenlos starten →